Psyched Wellness (CSE:PSYC, OTCQB:PSYCF) Ltd announced that it has appointed Matthew Singh as Chief Commercial Officer.
The Toronto-based psychedelic wellness company said that Singh will drive its development into a full-scale packaged goods provider as it prepares to launch its Amanita Muscaria (AME-1)-derived consumer products in 2022.
"I'm thrilled at the opportunity to level-up our executive team and organization as we transition from an R&D-focused start-up to a world-class CPG company," said Jeffrey Stevens, CEO of the Psyched Wellness (CSE:PSYC, OTCQB:PSYCF) in a statement.
READ: Psyched Wellness says Health Canada approves its request for adding Amanita muscaria mushrooms to Natural Health Products
He added: "Matt joining Psyched at this time demonstrates his confidence in the market opportunity of our proprietary extract of the Amanita Muscaria mushroom as a new entrant into the health and wellness category. Matt has already developed a strong sales and branding strategy since he started consulting with Psyched in June and joining us full-time in a leadership role shows the concentration we are putting into bringing our products to market next year."
Singh has an extensive track record of success launching brands, products, and corporate strategy within the multibillion-dollar beverage and pharmaceutical industries in Canada and internationally.
Accustomed to driving revenue into the hundreds of millions, Singh was previously the head of VPX Pharmaceuticals' numerous CPG properties, in Canada and East Asia, securing immediate profitability with each sports nutrition, energy drink, cannabis, and alcoholic good VPX added to their portfolio.
Prior to VPX, Singh spent almost a decade at Red Bull Canada, where he ran the company's Business Development department, and over seven years with Coca Cola. In addition, he is an integral contributor to multiple start-up endeavors as a consultant, board member, and advisor within the health, wellness, and digital intelligence verticals.
“It was an easy decision to join the team at Psyched full-time,” commented Singh.
He added: “We have developed a truly phenomenal product and look forward to multiple big announcements leading up to a market launch, in 2022. I have been fortunate to work with industry leaders and market disruptors in the extremely competitive beverage and pharmaceutical landscapes throughout my career, and the CPG potential already developed by the team at Psyched has me more excited than anything I have witnessed thus far.”
Psyched Wellness is a Canadian-based health supplements company dedicated to the distribution of mushroom-derived products and associated consumer packaged goods. The company's objective is to create premium mushroom-derived products that have the potential to become a leading North American brand in the emerging functional food category.
Contact Ritika at ritika@proactiveinvestors.com